Cargando…

Management of severe spasticity with and without dystonia with intrathecal baclofen in the pediatric population: a cross-sectional study

OBJECTIVE: To investigate the differences in delivery mode, daily dose, and catheter tip location in pediatric patients using intrathecal baclofen (ITB) pumps with spasticity plus dystonia versus spasticity alone. METHODS: A single-center, cross-sectional study was performed by collecting retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Gober, Joslyn, Seymour, Michelle, Miao, Hongyu, Curry, Daniel J., Thomas, Sruthi P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716860/
https://www.ncbi.nlm.nih.gov/pubmed/36475051
http://dx.doi.org/10.1136/wjps-2021-000407
_version_ 1784842780498984960
author Gober, Joslyn
Seymour, Michelle
Miao, Hongyu
Curry, Daniel J.
Thomas, Sruthi P.
author_facet Gober, Joslyn
Seymour, Michelle
Miao, Hongyu
Curry, Daniel J.
Thomas, Sruthi P.
author_sort Gober, Joslyn
collection PubMed
description OBJECTIVE: To investigate the differences in delivery mode, daily dose, and catheter tip location in pediatric patients using intrathecal baclofen (ITB) pumps with spasticity plus dystonia versus spasticity alone. METHODS: A single-center, cross-sectional study was performed by collecting retrospective data from electronic medical records. Demographic and diagnostic information was obtained, comparing patients with spasticity with or without dystonia. The data were analyzed for group differences using a two-tailed Student’s t-test. Categorical data were analyzed for group differences using Pearson’s χ(2) test. RESULTS: A total of 137 patients met the criteria. The majority (114) had spasticity plus dystonia whereas only 23 were documented as spasticity alone. Simple continuous dosing was the most common delivery mode, but flex dosing was used more than twice as frequently with spasticity plus dystonia compared with spasticity alone (42% vs 17%). Patients with spasticity plus dystonia also had more rostral catheter tip locations. CONCLUSIONS: While it has been discussed anecdotally, this study confirms the supposition that patients with spasticity plus dystonia have increased dose requirements when compared with those with spasticity alone. Although there are no clear standards of care when managing these patients, they are often on higher daily dosages, are more likely to require flexed dosing method, and have higher catheter placements. Still, there are few studies that demonstrate improvements in dystonia with the use of ITB. In general, these patients would benefit from the development of universal standardizations as well as the confirmation that this is an appropriate treatment.
format Online
Article
Text
id pubmed-9716860
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-97168602022-12-05 Management of severe spasticity with and without dystonia with intrathecal baclofen in the pediatric population: a cross-sectional study Gober, Joslyn Seymour, Michelle Miao, Hongyu Curry, Daniel J. Thomas, Sruthi P. World J Pediatr Surg Original Research OBJECTIVE: To investigate the differences in delivery mode, daily dose, and catheter tip location in pediatric patients using intrathecal baclofen (ITB) pumps with spasticity plus dystonia versus spasticity alone. METHODS: A single-center, cross-sectional study was performed by collecting retrospective data from electronic medical records. Demographic and diagnostic information was obtained, comparing patients with spasticity with or without dystonia. The data were analyzed for group differences using a two-tailed Student’s t-test. Categorical data were analyzed for group differences using Pearson’s χ(2) test. RESULTS: A total of 137 patients met the criteria. The majority (114) had spasticity plus dystonia whereas only 23 were documented as spasticity alone. Simple continuous dosing was the most common delivery mode, but flex dosing was used more than twice as frequently with spasticity plus dystonia compared with spasticity alone (42% vs 17%). Patients with spasticity plus dystonia also had more rostral catheter tip locations. CONCLUSIONS: While it has been discussed anecdotally, this study confirms the supposition that patients with spasticity plus dystonia have increased dose requirements when compared with those with spasticity alone. Although there are no clear standards of care when managing these patients, they are often on higher daily dosages, are more likely to require flexed dosing method, and have higher catheter placements. Still, there are few studies that demonstrate improvements in dystonia with the use of ITB. In general, these patients would benefit from the development of universal standardizations as well as the confirmation that this is an appropriate treatment. BMJ Publishing Group 2022-05-16 /pmc/articles/PMC9716860/ /pubmed/36475051 http://dx.doi.org/10.1136/wjps-2021-000407 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Gober, Joslyn
Seymour, Michelle
Miao, Hongyu
Curry, Daniel J.
Thomas, Sruthi P.
Management of severe spasticity with and without dystonia with intrathecal baclofen in the pediatric population: a cross-sectional study
title Management of severe spasticity with and without dystonia with intrathecal baclofen in the pediatric population: a cross-sectional study
title_full Management of severe spasticity with and without dystonia with intrathecal baclofen in the pediatric population: a cross-sectional study
title_fullStr Management of severe spasticity with and without dystonia with intrathecal baclofen in the pediatric population: a cross-sectional study
title_full_unstemmed Management of severe spasticity with and without dystonia with intrathecal baclofen in the pediatric population: a cross-sectional study
title_short Management of severe spasticity with and without dystonia with intrathecal baclofen in the pediatric population: a cross-sectional study
title_sort management of severe spasticity with and without dystonia with intrathecal baclofen in the pediatric population: a cross-sectional study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716860/
https://www.ncbi.nlm.nih.gov/pubmed/36475051
http://dx.doi.org/10.1136/wjps-2021-000407
work_keys_str_mv AT goberjoslyn managementofseverespasticitywithandwithoutdystoniawithintrathecalbaclofeninthepediatricpopulationacrosssectionalstudy
AT seymourmichelle managementofseverespasticitywithandwithoutdystoniawithintrathecalbaclofeninthepediatricpopulationacrosssectionalstudy
AT miaohongyu managementofseverespasticitywithandwithoutdystoniawithintrathecalbaclofeninthepediatricpopulationacrosssectionalstudy
AT currydanielj managementofseverespasticitywithandwithoutdystoniawithintrathecalbaclofeninthepediatricpopulationacrosssectionalstudy
AT thomassruthip managementofseverespasticitywithandwithoutdystoniawithintrathecalbaclofeninthepediatricpopulationacrosssectionalstudy